Skip to content
Application 201741
- Type
- ANDA
- Sponsor
- AM REGENT
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | OLANZAPINE | OLANZAPINE | INJECTABLE;INTRAMUSCULAR | 10MG/VIAL | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0517-0955 | Olanzapine | Olanzapine | American Regent, Inc. | ANDA | Current |
| 0517-0955 | Olanzapine | Olanzapine | American Regent, Inc. | ANDA | Current |
| 0517-0955 | Olanzapine | Olanzapine | American Regent, Inc. | ANDA | Current |
| 0517-0955 | Olanzapine | Olanzapine | American Regent, Inc. | ANDA | Current |
| 64725-0955 | Olanzapine | Olanzapine | TYA Pharmaceuticals | ANDA | Current |